WHC is still in active development. Read this to understand our approach.
depiction of QVYRGXJJSLMXQH-UHFFFAOYSA-N.svg
psychonaut

Orphenadrine

Verificar en psychonaut

isomerdesign

Orphenadrine

Verificar en isomerdesign

pubchem

Orphenadrine

Verificar en pubchem

drugmap

Orphenadrine

Verificar en drugmap

wiki

Orphenadrine

Verificar en wiki

Data

InChI: InChI=1S/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3

Sinónimos: NCGC00089814-05,NCGC00089814-02,Mefenamine,Biorphen,A899996,N,N-Dimethyl-2-(2-methylbenzylhydroxy)ethylamine,ORPHENADRINE [VANDF], Mefenamine,Orphenadine,KBioSS_001525,o-Monomethyldiphenhydramine,Orphenadinum, Mialgin (TN),NCGC00015771-22, Orfro, Orphenate,KBio1_000853,Orphenate,Orphenadrinum,NCGC00015771-06, N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamin, Banflex (TN),BSPBio_000317, Brocadisipal, Orphenadine,NCGC00015771-07,beta-Dimethylaminoethyl-2-methylbenzhydryl ether,Norgesic, 2-Methyldiphenhydramine,BSPBio_002141,KBio2_001525,CHEMBL900,N,N-Dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine #, Mephenamine,Ethanamine, N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-,NCGC00015771-03,DB01173,BDBM50062614,Mialgin (TN), Orphenadrine [INN:BAN],N,N-dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine,Orfenadrina [INN-Spanish], Orphenadinum, N,N-Dimethyl-2-[(o-methyl-alpha-phenylbenzyl)oxy]ethylamine, O-Methyldiphenhydramine, Orphenadrinum,beta-Dimethylaminoethyl 2-methylbenzhydryl ether,Orfenadrina,Oprea1_476547,AB00053510_20, Phenyl-o-tolylmethyl dimethyaminoethyl ether,Ethylamine, N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)-, N,N-dimethyl-2-{[(2-methylphenyl)(phenyl)methyl]oxy}ethanamine,Spectrum5_001036,SPBio_001255,ORP,SPBio_002238,SCHEMBL28727, Brocasipal (TN),Orphenedrine,UNII-AL805O9OG9,N,N-Dimethyl-2-[(o-methyl-alpha-phenylbenzyl)oxy]ethylamine,Lopac0_000884,NCGC00015771-12,AL805O9OG9, Biorphen, Myotrol,SBI-0050859.P004,DivK1c_000853,dimethyl-2[alpha-(o-tolyl)benzyloxy]ethylamine, Disipal (TN),KBio3_001641, Beta-Dimethylaminoethyl-2-methylbenzhydryl ether, Orfenadrina [INN-Spanish], Beta-Dimethylaminoethyl 2-methylbenzhydryl ether,N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine,Phenyl-o-tolylmethyl dimethylaminoethyl ether,Spectrum2_001038, Norflex (TN), Brocasipal,dimethyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine,o-Methyldiphenhydramine,AB00053510_21, Orphenadrine(INN),Spectrum3_000531,ORPHENADRINE [WHO-DD],N,N-Dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine,Spectrum4_000460, Myolin,WS 2434,Orphenadrine, N,N-Dimethyl-2-(o-methyl-alpha-phenylbenzyl)oxy)ethylamine,NCGC00015771-10, Disipal,ORPHENADRINE [HSDB],Disipal,Prestwick2_000239, Flexon (TN), Norflex Orphenadrine Citrate,ETHANAMINE, N,N-DIMETHYL-2-((2-METHYLPHENYL)PHENYLMETHOXY)-, (+/-)-,C07935,Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-,Invagesic,Spectrum_001045,ORPHENADRINE [INN], Lysantin,Phenyl-o-tolylmethyl dimethyaminoethyl ether,CBDivE_006102, Orphenedrine, Mephenamin (TN),NCGC00089814-03,L001253,orphenadrine,NINDS_000853, 2-(Phenyl-o-tolylmethoxy)ethyldimethylamine,N,N-dimethyl-2-{[(2-methylphenyl)(phenyl)methyl]oxy}ethanamine,GTPL7251,Orphenadrin, Orfenadrina,Brocasipal (Salt/Mix),Orphenadrine (INN),N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine,.beta.-Dimethylaminoethyl 2-methylbenzhydryl ether, Methyldiphenylhydramine,IDI1_000853,NCGC00015771-05, Orphenadrin,BPBio1_000349, ORP,BS-5930,EN300-708773, Sodium Mefenamine, Orphenadrinum [INN-Latin],Antiflex, N,N-dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine,BRD-A53576514-003-03-1, N,N-Dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine,DTXSID3023396, Biorphen (TN),BRN 1885151,KBio2_004093,Orphengesic,Orfenadin,D08305, WS 2434,Q3292273,2-(Phenyl-o-tolylmethoxy)ethyldimethylamine,Orphenadrinum [INN-Latin],Dimethyl-[2-(phenyl-o-tolyl-methoxy)-ethyl]-amine,ORPHENADRINE [MI],SDCCGSBI-0050859.P005,AB00053510,BRD-A53576514-048-06-9,N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamin,Orphenadrine [INN:BAN], O-Monomethyldiphenhydramine,(+/-)-N,N-DIMETHYL-2-((O-METHYL-.ALPHA.-PHENYLBENZYL)OXY)ETHYLAMINE,Prestwick3_000239,NCGC00015771-09,Brocadisipal,CCG-204966,HSDB 3139, N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine,83-98-7,EINECS 201-509-2,CHEBI:7789,N,N-Dimethyl-2-[(o-methyl-.alpha.-phenylbenzyl)oxy]ethylamine,MEFENAMINE [JAN],KBioGR_000880,2-Methyldiphenhydramine,Mephenamine (Salt/Mix),4-06-00-04727 (Beilstein Handbook Reference),Ethylamine, N,N-dimethyl-2-((o-methyl-.alpha.-phenylbenzyl)oxy)-,Prestwick1_000239,AB00053510-19,N,N-Dimethyl-2-(o-methyl-alpha-phenylbenzyl)oxy)ethylamine,KBio2_006661,Prestwick0_000239

Estimated data

Solubilidad: -2.937 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 50.7% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.